Aveo Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,784
| Closed | -$1.07M | – | 88 |
|
|
2025
Q1 | $1.07M | Sell |
6,784
-1,423
| -17% | -$223K | 0.18% | 75 |
|
|
2024
Q4 | $1.19M | Buy |
8,207
+1,194
| +17% | +$185K | 0.13% | 119 |
|
|
2024
Q3 | $1.14M | Sell |
7,013
-2,029
| -22% | -$323K | 0.12% | 125 |
|
|
2024
Q2 | $1.32M | Sell |
9,042
-354
| -4% | -$52.6K | 0.15% | 109 |
|
|
2024
Q1 | $1.4M | Buy |
9,396
+1,926
| +26% | +$307K | 0.15% | 115 |
|
|
2023
Q4 | $1.17M | Sell |
7,470
-447
| -6% | -$68.5K | 0.14% | 116 |
|
|
2023
Q3 | $1.23M | Buy |
7,917
+29
| +0.4% | +$4.79K | 0.16% | 113 |
|
|
2023
Q2 | $1.31M | Hold |
7,888
| – | – | 0.17% | 110 |
|
|
2023
Q1 | $1.22M | Sell |
7,888
-4,619
| -37% | -$746K | 0.16% | 101 |
|
|
2022
Q4 | $2.21M | Sell |
12,507
-1,361
| -10% | -$235K | 0.33% | 70 |
|
|
2022
Q3 | $2.27M | Sell |
13,868
-2,064
| -13% | -$349K | 0.39% | 64 |
|
|
2022
Q2 | $2.83M | Sell |
15,932
-1,779
| -10% | -$317K | 0.46% | 61 |
|
|
2022
Q1 | $3.14M | Sell |
17,711
-8,348
| -32% | -$1.42M | 0.55% | 54 |
|
|
2021
Q4 | $4.46M | Buy |
26,059
+20,077
| +336% | +$3.29M | 0.8% | 33 |
|
|
2021
Q3 | $966K | Buy |
5,982
+676
| +13% | +$115K | 0.2% | 101 |
|
|
2021
Q2 | $874K | Buy |
5,306
+40
| +0.8% | +$6.62K | 0.19% | 112 |
|
|
2021
Q1 | $866K | Buy |
5,266
+3,572
| +211% | +$578K | 0.22% | 93 |
|
|
2020
Q4 | $267K | Sell |
1,694
-1,878
| -53% | -$277K | 0.41% | 54 |
|
|
2020
Q3 | $532K | Buy |
+3,572
| New | +$529K | 0.19% | 106 |
|
|
2020
Q2 | – | Sell |
-3,538
| Closed | -$464K | – | 104 |
|
|
2020
Q1 | $464K | Sell |
3,538
-346
| -9% | -$49.1K | 0.23% | 95 |
|
|
2019
Q4 | $567K | Sell |
3,884
-122
| -3% | -$16.5K | 0.22% | 99 |
|
|
2019
Q3 | $522K | Buy |
4,006
+87
| +2% | +$11.5K | 0.22% | 98 |
|
|
2019
Q2 | $509K | Buy |
3,919
+48
| +1% | +$6.64K | 0.22% | 99 |
|
|
2019
Q1 | $541K | Buy |
3,871
+92
| +2% | +$12.3K | 0.25% | 83 |
|
|
2018
Q4 | $488K | Sell |
3,779
-257
| -6% | -$35.8K | 0.24% | 64 |
|
|
2018
Q3 | $560K | Sell |
4,036
-1,975
| -33% | -$262K | 0.25% | 64 |
|
|
2018
Q2 | $729K | Sell |
6,011
-446
| -7% | -$55.6K | 0.32% | 56 |
|
|
2018
Q1 | $827K | Buy |
6,457
+768
| +13% | +$104K | 0.35% | 51 |
|
|
2017
Q4 | $795K | Buy |
5,689
+561
| +11% | +$78.1K | 0.26% | 47 |
|
|
2017
Q3 | $667K | Sell |
5,128
-197
| -4% | -$26.1K | 0.23% | 54 |
|
|
2017
Q2 | $704K | Buy |
5,325
+288
| +6% | +$36.7K | 0.25% | 51 |
|
|
2017
Q1 | $627K | Sell |
5,037
-4,516
| -47% | -$539K | 0.23% | 47 |
|
|
2016
Q4 | $1.1M | Buy |
+9,553
| New | +$1.1M | 0.31% | 59 |
|
Other funds holding JNJ
Aveo Capital Partners's JNJ Position: Q2 2025 in Review
Aveo Capital Partners sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 6,784 shares — an estimated $1.07M sold.
Aveo Capital Partners first reported a position in JNJ in Q4 2016 and held it in 33 quarters. The position peaked at $4.46M in Q4 2021. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.
- Aveo Capital Partners reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
- Aveo Capital Partners sold 6,784 Johnson & Johnson shares in Q2 2025, an estimated $1.07M.
- Aveo Capital Partners first reported a position in Johnson & Johnson in Q4 2016 and held it in 33 quarters.
- Aveo Capital Partners's Johnson & Johnson position peaked at $4.46M in Q4 2021.
- 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.
Based on Aveo Capital Partners's 13F filing for Q2 2025.